Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Preceptorship on Ovarian Cancer 2021

06 - 07 Sep 2021

Virtual

ESMO-Preceptorship-Ovarian-Cancer-1000x1000

Slides and webcasts from all ESMO Preceptorship courses are open to all with at least a free ESMO account, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The use of these presentations is for personal educational purposes only.

Learning objectives
  • To learn about best clinical practice in the multidisciplinary management of early and late stage ovarian cancer, and the management of patients with symptoms of the disease and the side-effects of treatment
  • To understand the importance of biology and pathology of common and rare ovarian tumours, the options for treatment of recurrent disease and how treatment-decisions are made, the novel therapeutic agents being developed to treat ovarian cancer and how knowledge of genomics and molecular pathways guides drug development

This event has been supported by an unrestricted educational grant from AstraZeneca and MSD.

Hide
Filter by:

There are 24 resources available

Biology of Drug Resistance

Presenter: G. Baldassarre, IT

Session: Session 5 - To Prepare the Future

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.